D-LAP5.Na

NMDA receptor antagonist

Catalog No. SIH-414

0 out of 5 based on 0 customer ratings
CAS No. 1303993-72-7
Molecular Formula C5H12NO5P•Na
SKU: SIH-414 Categories: ,

Clear
SIH-414_DLAP5-NA_Chemical_Structure.png
Product Name D-LAP5.Na
Description

NMDA receptor antagonist

Purity >99.0
CAS No. 1303993-72-7
Molecular Formula C5H12NO5P•Na
Molecular Weight 219.11
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Antagonist
Solubility Soluble to 100 mM in water
Source Synthetic
Appearance White solid
SMILES C([P](O)(O)=O)CCC(C(O)=O)N
Safety Phrases Classification: Not WHMIS controlled.
Safety Phrases:
S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
Cite This Product D-LAP5.Na (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-414)

Biological Description

Alternative Names DL-amino-5-phosphonopentaoic acid sodium salt
Research Areas Glutamate Receptors, Ion Channels, Neuroscience, Neurotransmitter Receptors, NMDA Receptors
Scientific Background DLAP5 is a racemic mixture. It is used widely as a potent and selective NMDA receptor antagonist. It represents the active enantiomer form of AP5 (2-amino-5-phosphonopentanoic acid).
References 1. Davies J., & Watkins J. (1982) Brain Res. 378-86.
2. Schulte M., Roon R., Chalmers D., Sunter D., & Koerner J. (1994) Brain Res. 203-7.

Product Images

<p>Chemical structure of D-LAP5.Na (SIH-414), a Glutamate-NMDA receptor antagonist. CAS #: 1303993-72-7. Molecular Formula: C5H12NO5P.Na. Molecular Weight: 219.11 g/mol.</p>

Chemical structure of D-LAP5.Na (SIH-414), a Glutamate-NMDA receptor antagonist. CAS #: 1303993-72-7. Molecular Formula: C5H12NO5P.Na. Molecular Weight: 219.11 g/mol.

Reviews

Reviews

There are no reviews yet.

Be the first to review “D-LAP5.Na”

Your email address will not be published. Required fields are marked *